505 results on '"Gotoh, Akihiko"'
Search Results
2. Predictive significance of high neutrophil ratio for thrombosis in myeloproliferative neoplasms: JSH-MPN-R18 subanalysis
3. Robot therapy aids mental health in patients with hematological malignancy during hematopoietic stem cell transplantation in a protective isolation unit
4. Combination of an aurora kinase inhibitor and the ABL tyrosine kinase inhibitor asciminib against ABL inhibitor-resistant CML cells
5. Correction to: Predictive significance of high neutrophil ratio for thrombosis in myeloproliferative neoplasms: JSH-MPN-R18 subanalysis
6. Interim analysis of post-marketing surveillance of ravulizumab for paroxysmal nocturnal hemoglobinuria in Japan
7. Effect of asciminib and vitamin K2 on Abelson tyrosine-kinase-inhibitor-resistant chronic myelogenous leukemia cells
8. WEE1 and PARP-1 play critical roles in myelodysplastic syndrome and acute myeloid leukemia treatment
9. Clinical characteristics of Japanese patients with polycythemia vera: results of the JSH-MPN-R18 study
10. Efficacy and safety of ropeginterferon alfa-2b in Japanese patients with polycythemia vera: an open-label, single-arm, phase 2 study
11. Therapeutic targeting of PFKFB3 and PFKFB4 in multiple myeloma cells under hypoxic conditions
12. Clinical characteristics, prognostic factors, and outcomes of patients with essential thrombocythemia in Japan: the JSH-MPN-R18 study
13. Dexamethasone Treatment for COVID-19-Related Lung Injury in an Adult with WHIM Syndrome
14. Philadelphia chromosome-negative myeloproliferative neoplasms: clinical aspects and treatment options
15. Correction to: Efficacy and safety of ropeginterferon alfa-2b in Japanese patients with polycythemia vera: an open-label, single-arm, phase 2 study
16. Glutaminase 1 plays critical roles in myelodysplastic syndrome and acute myeloid leukemia cells.
17. Effects of bortezomib on ponatinib-resistant Philadelphia chromosome-positive cells
18. Interferon therapy for pregnant patients with essential thrombocythemia in Japan
19. Targeting phosphoinositide 3-kinases and histone deacetylases in multiple myeloma
20. Expression of L-type amino acid transporter 1 is a poor prognostic factor for Non-Hodgkin’s lymphoma
21. Effect of dual inhibition of histone deacetylase and phosphatidylinositol-3 kinase in Philadelphia chromosome-positive leukemia cells
22. Correction to: Dexamethasone Treatment for COVID-19-Related Lung Injury in an Adult with WHIM Syndrome
23. Vitamin B6 deficiency is prevalent in primary and secondary myelofibrosis patients
24. P1060: THE IMPACT OF POLYCYTHEMIA VERA ON DAILY LIVING, AND SYMPTOM AND TREATMENT PERCEPTION GAPS BETWEEN PATIENTS AND PHYSICIANS: RESULTS OF A CROSS-SECTIONAL SURVEY IN JAPAN
25. P661: EFFECT OF VITAMIN K2 ON COVID-19 S1 PROTEIN-INDUCED CYTOTOXICITY AGAINST HUVECS AND ON THE ACTION OF ASCIMINIB IN ABELSON-TYROSINE-KINASE-INHIBITOR-RESISTANT CHRONIC MYELOGENOUS LEUKEMIA CELLS
26. A cross-sectional survey of symptoms and daily living among patients with polycythemia vera and their treating physicians in Japan
27. Cholesterol levels of Japanese dyslipidaemic patients with various comorbidities: BioBank Japan
28. Gilteritinib Affects the Selection of Dominant Clones in Clonal Hematopoiesis: Sequential Genetic Analysis of an FLT3-ITD Positive AML Patient with Long-Term Gilteritinib Therapy
29. Mutational subtypes of JAK2 and CALR correlate with different clinical features in Japanese patients with myeloproliferative neoplasms
30. RS3PE syndrome with angioimmunoblastic T-cell lymphoma early after the start of immunosuppressive therapy
31. Clinical features of primary vitreoretinal lymphoma developing extra‐central nervous system (CNS)/testicular lymphomas with or without CNS involvement: A single‐centre study of 13 cases
32. WEE1 and PARP-1 play critical roles in myelodysplastic syndrome (MDS): A novel approach to targeted MDS therapy
33. A cross-sectional survey of symptoms and daily living among patients with polycythemia vera and their treating physicians in Japan
34. Iron overload patients with unknown etiology from national survey in Japan
35. A Practice-Oriented Genome Profiling Study with the Novel Halo-Shape Annealing and Defer-Ligation Enrichment (HANDLE) System : HM-Screen-JAPAN02
36. von Willebrand factor activity levels are influenced by driver mutation status in polycythemia vera and essential thrombocythemia patients with well‐controlled platelet counts
37. Co-occurrence of hyperleukocytosis and elevated fibrin–fibrinogen degradation product levels is a risk factor for early intracranial hemorrhage in patients with de novo acute leukemia
38. Pregnancy outcomes of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab: a Japanese experience and updated review
39. Tyrosine Kinase Inhibitors Do Not Promote a Decrease in SARS-CoV-2 Anti-Spike IgG after BNT162b2 Vaccination in Chronic Myeloid Leukemia: A Prospective Observational Study
40. O3-1 HM-SCREEN-Japan 01: a mutation profiling multicenter study on patients with acute myeloid leukemia
41. Clinical utility of genomic profiling of AML using paraffin‐embedded bone marrow clots: HM‐SCREEN‐Japan 01.
42. A pilot study examining the efficacy of hochuekkito for improving quality of life in patients with myeloproliferative neoplasms
43. Mutated KIT Tyrosine Kinase as a Novel Molecular Target in Acute Myeloid Leukemia
44. Additional file 1 of Therapeutic targeting of PFKFB3 and PFKFB4 in multiple myeloma cells under hypoxic conditions
45. Potential of a sphingosine 1‑phosphate receptor antagonist and sphingosine kinase inhibitors as targets for multiple myeloma treatment
46. Examination of the effect of immunosuppressive therapy on acquired hemophilia A in elderly patients with bloodstream infections
47. Effect of D-mannose on Philadelphia chromosome-positive leukemia cells
48. Dexamethasone Treatment for COVID-19-Related Lung Injury in an Adult with WHIM Syndrome
49. Rituximab plus a CHOP-like regimen, central nervous system prophylaxis, and contralateral testicular irradiation for localized primary testicular diffuse large B-cell lymphoma lead to prolonged progression-free survival
50. Blastic plasmacytoid dendritic cell neoplasm accompanied by autoimmune hemolytic anemia achieving complete remission with hydroxyurea and steroids
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.